Medline Industries, Inc., announces that it has been awarded a three-year group purchasing contract with Premier, a performance improvement alliance of more than 2,800 U.S. hospitals and 93,000 other healthcare sites, for its ReadyBath® patient body bathing products and incontinence skin protectant wipes. The agreement begins June 1, 2013.
Additionally, Medline was also awarded a sole source agreement for Premiers ASCEND (Accelerated Supply Chain Endeavor) program for the same product category. ASCEND assists Premier alliance member hospitals in ongoing efforts to control and reduce costs through simplified purchasing processes and specially negotiated contract benefits.
The contract provides Premier members with access to Medlines ReadyBath patient body bathing cloths, as well as an array of Medlines personal cleansing wipes, including: AloeTouch® Wet Wipes, ReadyFlush® Dispersible Wipes, and AloeTouch® PROTECT Skin Protectant Wipes with 3.2% dimethicone. The inclusion of dimethicone, as a skin barrier helps clinicians avoid skin breakdown, which is a primary focus of providers. The ReadyBath system includes single-use pre-moistened cloths with a rinse-free formula that cleans, moisturizes and conditions the skin. ReadyBath cloths are ready to use and disposable, which eliminates the need for basins, soaps, linens and lotions. By implementing a cost-effective, single-use bath-in-a-bag concept, clinicians are able to minimize the risk of cross-contamination while improving patient satisfaction.
Source: Medline Industries
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.